Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001615774-17-001730
Filing Date
2017-04-17
Accepted
2017-04-17 17:17:32
Documents
1
Period of Report
2017-04-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A s105896_pre14a.htm PRE 14A 664977
  Complete submission text file 0001615774-17-001730.txt   666091
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36019 | Film No.: 17765302
SIC: 2834 Pharmaceutical Preparations